Total Payments
$41,374
2024 Payments
$687.32
Companies
62
Transactions
814
Medicare Patients
10,462
Medicare Billing
$664,073
Payment Breakdown by Category
Other$24,630 (59.5%)
Food & Beverage$14,442 (34.9%)
Travel$1,771 (4.3%)
Education$532.22 (1.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $24,630 | 13 | 59.5% |
| Food and Beverage | $14,442 | 757 | 34.9% |
| Travel and Lodging | $1,771 | 19 | 4.3% |
| Education | $532.22 | 25 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $28,788 | 119 | $0 (2024) |
| Novo Nordisk Inc | $1,648 | 66 | $0 (2023) |
| Amgen Inc. | $1,139 | 62 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,091 | 53 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $916.96 | 40 | $0 (2024) |
| PFIZER INC. | $794.67 | 63 | $0 (2023) |
| GlaxoSmithKline, LLC. | $755.17 | 52 | $0 (2024) |
| Lilly USA, LLC | $586.75 | 35 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $578.37 | 28 | $0 (2024) |
| Merck Sharp & Dohme LLC | $466.14 | 35 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $687.32 | 36 | Corcept Therapeutics ($157.49) |
| 2023 | $715.08 | 26 | Novo Nordisk Inc ($133.23) |
| 2022 | $1,017 | 66 | Bayer HealthCare Pharmaceuticals Inc. ($136.74) |
| 2021 | $1,393 | 94 | AbbVie Inc. ($142.98) |
| 2020 | $1,497 | 95 | Amgen Inc. ($241.01) |
| 2019 | $7,988 | 181 | Janssen Pharmaceuticals, Inc ($5,263) |
| 2018 | $11,932 | 165 | Janssen Pharmaceuticals, Inc ($9,297) |
| 2017 | $16,145 | 151 | Janssen Pharmaceuticals, Inc ($13,874) |
All Payment Transactions
814 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Cardio-renal | ||||||
| 12/10/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: Endocrinology | ||||||
| 12/10/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $0.94 | General |
| Category: Endocrinology | ||||||
| 11/12/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $24.20 | General |
| Category: Endocrinology | ||||||
| 10/31/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Cardio-renal | ||||||
| 10/08/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: Endocrinology | ||||||
| 10/01/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: RESPIRATORY | ||||||
| 09/24/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: Inflammation | ||||||
| 09/17/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Endocrinology | ||||||
| 09/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: DIABETES | ||||||
| 09/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $52.11 | General |
| Category: Cardio-renal | ||||||
| 08/29/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: Bone Health | ||||||
| 08/27/2024 | Merck Sharp & Dohme LLC | CAPVAXIVE (Biological) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: VACCINE | ||||||
| 08/22/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Endocrinology | ||||||
| 08/22/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $0.70 | General |
| Category: Endocrinology | ||||||
| 08/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Inflammation | ||||||
| 08/01/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 07/23/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: Endocrinology | ||||||
| 07/12/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $23.36 | General |
| 07/10/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: Diabetes | ||||||
| 06/11/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $32.15 | General |
| Category: Endocrinology | ||||||
| 05/30/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $32.32 | General |
| Category: NEUROSCIENCE | ||||||
| 05/03/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $27.86 | General |
| Category: Diabetes | ||||||
| 04/23/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: Inflammation | ||||||
| 03/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 2,409 | 4,626 | $555,243 | $213,753 |
| 2022 | 22 | 2,517 | 4,286 | $543,790 | $173,044 |
| 2021 | 19 | 2,491 | 4,214 | $508,727 | $90,472 |
| 2020 | 24 | 3,045 | 4,901 | $563,983 | $186,804 |
Total Patients
10,462
Total Services
18,027
Medicare Billing
$664,073
Procedure Codes
86
All Medicare Procedures & Services
86 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 471 | 959 | $218,652 | $75,925 | 34.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 321 | 321 | $86,670 | $39,329 | 45.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 176 | 179 | $27,570 | $13,509 | 49.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 165 | 233 | $35,416 | $12,573 | 35.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 483 | 1,311 | $18,354 | $10,958 | 59.7% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 38 | 286 | $31,692 | $10,672 | 33.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 32 | 32 | $16,943 | $8,956 | 52.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 25 | 191 | $24,309 | $8,918 | 36.7% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 25 | 226 | $16,930 | $8,095 | 47.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 51 | 60 | $18,420 | $6,921 | 37.6% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 38 | 166 | $16,567 | $6,211 | 37.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 189 | 192 | $7,692 | $5,789 | 75.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 219 | 233 | $23,766 | $2,142 | 9.0% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 16 | 37 | $3,004 | $1,138 | 37.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 32 | 32 | $1,216 | $964.80 | 79.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 31 | 67 | $3,685 | $517.07 | 14.0% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 12 | 12 | $820.08 | $401.88 | 49.0% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 21 | 21 | $794.01 | $298.20 | 37.6% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 20 | 21 | $798.00 | $169.20 | 21.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 16 | 19 | $1,330 | $144.59 | 10.9% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2023 | 28 | 28 | $616.00 | $120.12 | 19.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 480 | 1,038 | $236,489 | $63,737 | 27.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 340 | 340 | $91,662 | $27,112 | 29.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 70 | 71 | $37,592 | $19,722 | 52.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 181 | 247 | $37,544 | $13,690 | 36.5% |
About Dr. Michael Caplan, MD
Dr. Michael Caplan, MD is a Internal Medicine healthcare provider based in Danville, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1275572562.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Caplan, MD has received a total of $41,374 in payments from pharmaceutical and medical device companies, with $687.32 received in 2024. These payments were reported across 814 transactions from 62 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($24,630).
As a Medicare-enrolled provider, Caplan has provided services to 10,462 Medicare beneficiaries, totaling 18,027 services with total Medicare billing of $664,073. Data is available for 4 years (2020–2023), covering 86 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Danville, VA
- Active Since 06/05/2006
- Last Updated 07/27/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1275572562
Products in Payments
- INVOKANA (Drug) $27,975
- ENTRESTO (Drug) $916.96
- XARELTO (Drug) $801.76
- JARDIANCE (Drug) $653.52
- FARXIGA (Drug) $550.29
- Ozempic (Drug) $418.08
- Prolia (Biological) $395.01
- Vascepa (Drug) $369.08
- Saxenda (Drug) $298.24
- UBRELVY (Drug) $271.56
- Kerendia (Drug) $269.32
- TRULICITY (Drug) $225.50
- VRAYLAR (Drug) $224.38
- ANORO (Drug) $222.22
- ELIQUIS (Drug) $221.23
- TRELEGY ELLIPTA (Drug) $203.46
- Repatha (Biological) $190.78
- LYRICA (Drug) $179.56
- FASENRA (Drug) $161.01
- Korlym (Drug) $157.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Danville
Dr. Christopher Still, D.o, D.O
Internal Medicine — Payments: $461,951
Internal Medicine $461,951
Dr. Brendan Carry, M.d, M.D
Internal Medicine — Payments: $209,824
Internal Medicine $209,824
Prince Anand, M.d, M.D
Internal Medicine — Payments: $188,555
Internal Medicine $188,555
Jessica Mckee, D.o, D.O
Internal Medicine — Payments: $57,390
Internal Medicine $57,390
Dr. Mark Reginato, M.d, M.D
Internal Medicine — Payments: $23,997
Internal Medicine $23,997
Mobasser Mahmood, M.d, M.D
Internal Medicine — Payments: $23,322
Internal Medicine $23,322